Older lung cancer patients face significant treatment burden

January 6, 2017

Depending on the type of treatment older lung cancer patients receive, they can spend an average of one in three days interacting with the healthcare system in the first 60 days after surgery or radiation therapy, according to a study by Yale researchers.

The findings are published in current issue of Journal of Oncology Practice.

"To our knowledge, this is the first study to characterize burden for early-stage in terms of touches with the healthcare system, including emergency department visits, hospital-based follow-up care, number of physicians, and outpatient visits," said first author Carolyn Presley, M.D., instructor at Yale Cancer Center and a Robert Wood Johnson Clinical Scholar at Yale School of Medicine.

"These findings highlight a need to improve cancer care coordination. It's also a call for providers to think about the burden we might be placing on patients," she noted.

Presley and her co-authors compared a group of 8,000 Medicare beneficiaries receiving treatment for early stage ; 76% were treated with surgery, 10% received stereotactic body (SBRT), and 13% received external-beam radiation therapy (EBRT).

According to the study, patients with a higher number of medical conditions treated with surgery had the most post-treatment burdens.

"We found that after a typical treatment for cancer, older patients saw an average of 20 different physicians during multiple visits and took 12 different medications," said Presley, who is also a member of the Yale Cancer Outcomes, Public Policy and Effectiveness Research Center. "These numbers are very high and a lot to expect of older patients who often have mobility issues or functional limitations. With every additional visit and prescription, there is additional room for errors."

"For who have more comorbidities—chronic conditions, like hypertension or diabetes, etc.—it's reasonable to strongly consider prescribing SBRT, vs. surgery or EBRT. SBRT radiation involves fewer treatment days," added Presley, who stressed that there should be a focus on streamlining cancer treatment so the patient spends the least amount of time interacting with the healthcare system.

"We have to start incorporating the patient voice in treatment decisions and really investing in case management and care coordination," said Presley. "Reducing the number of visits, scheduling them on the same days, and reducing redundant tests, labs, and medications would greatly improve the daily lives of ."

Explore further: Widespread adoption of SBRT has improved survival rates for elderly patients with early stage lung cancer

More information: Journal of Oncology Practice, DOI: 10.1200/JOP.2016.014100

Related Stories

Recommended for you

Ancient stress response provides clues to cancer resistance

April 25, 2017

Cancer is often able to craftily outwit the best techniques modern medicine has developed to treat it. In an attempt to understand and combat cancer's vaunted prowess, an unusual collaboration between physicists and a leading ...

Studying a catalyst for blood cancers

April 25, 2017

Imagine this scenario on a highway: A driver starts to make a sudden lane change but realizes his mistake and quickly veers back, too late. Other motorists have already reacted and, in some cases, collide. Meanwhile, the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.